Medical Care
Global Real-World Evidence in Healthcare Market Research Report 2025
- May 05, 25
- ID: 226433
- Pages: 84
- Figures: 86
- Views: 29
The global market for Real-World Evidence in Healthcare was valued at US$ 466 million in the year 2024 and is projected to reach a revised size of US$ 803 million by 2031, growing at a CAGR of 8.2% during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Real-World Evidence in Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Real-World Evidence in Healthcare.
The Real-World Evidence in Healthcare market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Real-World Evidence in Healthcare market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Real-World Evidence in Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Anthem
IQVIA
ICON
PPD
Clinigen Group
Cognizant Technology Solutions Corporation
Oracle
Parexel
PerkinElmer
SAS Institute
UnitedHealth Group
Flatiron Health
Segment by Type
Service
Data Set
Segment by Application
Drug Development and Approval
Development and Approval of Medical Devices
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Real-World Evidence in Healthcare company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Real-World Evidence in Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Real-World Evidence in Healthcare.
The Real-World Evidence in Healthcare market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Real-World Evidence in Healthcare market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Real-World Evidence in Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Anthem
IQVIA
ICON
PPD
Clinigen Group
Cognizant Technology Solutions Corporation
Oracle
Parexel
PerkinElmer
SAS Institute
UnitedHealth Group
Flatiron Health
Segment by Type
Service
Data Set
Segment by Application
Drug Development and Approval
Development and Approval of Medical Devices
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Real-World Evidence in Healthcare company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Real-World Evidence in Healthcare Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Service
1.2.3 Data Set
1.3 Market by Application
1.3.1 Global Real-World Evidence in Healthcare Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Development and Approval
1.3.3 Development and Approval of Medical Devices
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Real-World Evidence in Healthcare Market Perspective (2020-2031)
2.2 Global Real-World Evidence in Healthcare Growth Trends by Region
2.2.1 Global Real-World Evidence in Healthcare Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Real-World Evidence in Healthcare Historic Market Size by Region (2020-2025)
2.2.3 Real-World Evidence in Healthcare Forecasted Market Size by Region (2026-2031)
2.3 Real-World Evidence in Healthcare Market Dynamics
2.3.1 Real-World Evidence in Healthcare Industry Trends
2.3.2 Real-World Evidence in Healthcare Market Drivers
2.3.3 Real-World Evidence in Healthcare Market Challenges
2.3.4 Real-World Evidence in Healthcare Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Real-World Evidence in Healthcare Players by Revenue
3.1.1 Global Top Real-World Evidence in Healthcare Players by Revenue (2020-2025)
3.1.2 Global Real-World Evidence in Healthcare Revenue Market Share by Players (2020-2025)
3.2 Global Real-World Evidence in Healthcare Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Real-World Evidence in Healthcare Revenue
3.4 Global Real-World Evidence in Healthcare Market Concentration Ratio
3.4.1 Global Real-World Evidence in Healthcare Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Real-World Evidence in Healthcare Revenue in 2024
3.5 Global Key Players of Real-World Evidence in Healthcare Head office and Area Served
3.6 Global Key Players of Real-World Evidence in Healthcare, Product and Application
3.7 Global Key Players of Real-World Evidence in Healthcare, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Real-World Evidence in Healthcare Breakdown Data by Type
4.1 Global Real-World Evidence in Healthcare Historic Market Size by Type (2020-2025)
4.2 Global Real-World Evidence in Healthcare Forecasted Market Size by Type (2026-2031)
5 Real-World Evidence in Healthcare Breakdown Data by Application
5.1 Global Real-World Evidence in Healthcare Historic Market Size by Application (2020-2025)
5.2 Global Real-World Evidence in Healthcare Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Real-World Evidence in Healthcare Market Size (2020-2031)
6.2 North America Real-World Evidence in Healthcare Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Real-World Evidence in Healthcare Market Size by Country (2020-2025)
6.4 North America Real-World Evidence in Healthcare Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Real-World Evidence in Healthcare Market Size (2020-2031)
7.2 Europe Real-World Evidence in Healthcare Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Real-World Evidence in Healthcare Market Size by Country (2020-2025)
7.4 Europe Real-World Evidence in Healthcare Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Real-World Evidence in Healthcare Market Size (2020-2031)
8.2 Asia-Pacific Real-World Evidence in Healthcare Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2020-2025)
8.4 Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Real-World Evidence in Healthcare Market Size (2020-2031)
9.2 Latin America Real-World Evidence in Healthcare Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Real-World Evidence in Healthcare Market Size by Country (2020-2025)
9.4 Latin America Real-World Evidence in Healthcare Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Real-World Evidence in Healthcare Market Size (2020-2031)
10.2 Middle East & Africa Real-World Evidence in Healthcare Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2020-2025)
10.4 Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anthem
11.1.1 Anthem Company Details
11.1.2 Anthem Business Overview
11.1.3 Anthem Real-World Evidence in Healthcare Introduction
11.1.4 Anthem Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.1.5 Anthem Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Details
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Real-World Evidence in Healthcare Introduction
11.2.4 IQVIA Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.2.5 IQVIA Recent Development
11.3 ICON
11.3.1 ICON Company Details
11.3.2 ICON Business Overview
11.3.3 ICON Real-World Evidence in Healthcare Introduction
11.3.4 ICON Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.3.5 ICON Recent Development
11.4 PPD
11.4.1 PPD Company Details
11.4.2 PPD Business Overview
11.4.3 PPD Real-World Evidence in Healthcare Introduction
11.4.4 PPD Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.4.5 PPD Recent Development
11.5 Clinigen Group
11.5.1 Clinigen Group Company Details
11.5.2 Clinigen Group Business Overview
11.5.3 Clinigen Group Real-World Evidence in Healthcare Introduction
11.5.4 Clinigen Group Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.5.5 Clinigen Group Recent Development
11.6 Cognizant Technology Solutions Corporation
11.6.1 Cognizant Technology Solutions Corporation Company Details
11.6.2 Cognizant Technology Solutions Corporation Business Overview
11.6.3 Cognizant Technology Solutions Corporation Real-World Evidence in Healthcare Introduction
11.6.4 Cognizant Technology Solutions Corporation Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.6.5 Cognizant Technology Solutions Corporation Recent Development
11.7 Oracle
11.7.1 Oracle Company Details
11.7.2 Oracle Business Overview
11.7.3 Oracle Real-World Evidence in Healthcare Introduction
11.7.4 Oracle Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.7.5 Oracle Recent Development
11.8 Parexel
11.8.1 Parexel Company Details
11.8.2 Parexel Business Overview
11.8.3 Parexel Real-World Evidence in Healthcare Introduction
11.8.4 Parexel Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.8.5 Parexel Recent Development
11.9 PerkinElmer
11.9.1 PerkinElmer Company Details
11.9.2 PerkinElmer Business Overview
11.9.3 PerkinElmer Real-World Evidence in Healthcare Introduction
11.9.4 PerkinElmer Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.9.5 PerkinElmer Recent Development
11.10 SAS Institute
11.10.1 SAS Institute Company Details
11.10.2 SAS Institute Business Overview
11.10.3 SAS Institute Real-World Evidence in Healthcare Introduction
11.10.4 SAS Institute Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.10.5 SAS Institute Recent Development
11.11 UnitedHealth Group
11.11.1 UnitedHealth Group Company Details
11.11.2 UnitedHealth Group Business Overview
11.11.3 UnitedHealth Group Real-World Evidence in Healthcare Introduction
11.11.4 UnitedHealth Group Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.11.5 UnitedHealth Group Recent Development
11.12 Flatiron Health
11.12.1 Flatiron Health Company Details
11.12.2 Flatiron Health Business Overview
11.12.3 Flatiron Health Real-World Evidence in Healthcare Introduction
11.12.4 Flatiron Health Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.12.5 Flatiron Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Real-World Evidence in Healthcare Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Service
1.2.3 Data Set
1.3 Market by Application
1.3.1 Global Real-World Evidence in Healthcare Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Development and Approval
1.3.3 Development and Approval of Medical Devices
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Real-World Evidence in Healthcare Market Perspective (2020-2031)
2.2 Global Real-World Evidence in Healthcare Growth Trends by Region
2.2.1 Global Real-World Evidence in Healthcare Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Real-World Evidence in Healthcare Historic Market Size by Region (2020-2025)
2.2.3 Real-World Evidence in Healthcare Forecasted Market Size by Region (2026-2031)
2.3 Real-World Evidence in Healthcare Market Dynamics
2.3.1 Real-World Evidence in Healthcare Industry Trends
2.3.2 Real-World Evidence in Healthcare Market Drivers
2.3.3 Real-World Evidence in Healthcare Market Challenges
2.3.4 Real-World Evidence in Healthcare Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Real-World Evidence in Healthcare Players by Revenue
3.1.1 Global Top Real-World Evidence in Healthcare Players by Revenue (2020-2025)
3.1.2 Global Real-World Evidence in Healthcare Revenue Market Share by Players (2020-2025)
3.2 Global Real-World Evidence in Healthcare Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Real-World Evidence in Healthcare Revenue
3.4 Global Real-World Evidence in Healthcare Market Concentration Ratio
3.4.1 Global Real-World Evidence in Healthcare Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Real-World Evidence in Healthcare Revenue in 2024
3.5 Global Key Players of Real-World Evidence in Healthcare Head office and Area Served
3.6 Global Key Players of Real-World Evidence in Healthcare, Product and Application
3.7 Global Key Players of Real-World Evidence in Healthcare, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Real-World Evidence in Healthcare Breakdown Data by Type
4.1 Global Real-World Evidence in Healthcare Historic Market Size by Type (2020-2025)
4.2 Global Real-World Evidence in Healthcare Forecasted Market Size by Type (2026-2031)
5 Real-World Evidence in Healthcare Breakdown Data by Application
5.1 Global Real-World Evidence in Healthcare Historic Market Size by Application (2020-2025)
5.2 Global Real-World Evidence in Healthcare Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Real-World Evidence in Healthcare Market Size (2020-2031)
6.2 North America Real-World Evidence in Healthcare Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Real-World Evidence in Healthcare Market Size by Country (2020-2025)
6.4 North America Real-World Evidence in Healthcare Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Real-World Evidence in Healthcare Market Size (2020-2031)
7.2 Europe Real-World Evidence in Healthcare Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Real-World Evidence in Healthcare Market Size by Country (2020-2025)
7.4 Europe Real-World Evidence in Healthcare Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Real-World Evidence in Healthcare Market Size (2020-2031)
8.2 Asia-Pacific Real-World Evidence in Healthcare Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2020-2025)
8.4 Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Real-World Evidence in Healthcare Market Size (2020-2031)
9.2 Latin America Real-World Evidence in Healthcare Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Real-World Evidence in Healthcare Market Size by Country (2020-2025)
9.4 Latin America Real-World Evidence in Healthcare Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Real-World Evidence in Healthcare Market Size (2020-2031)
10.2 Middle East & Africa Real-World Evidence in Healthcare Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2020-2025)
10.4 Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anthem
11.1.1 Anthem Company Details
11.1.2 Anthem Business Overview
11.1.3 Anthem Real-World Evidence in Healthcare Introduction
11.1.4 Anthem Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.1.5 Anthem Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Details
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Real-World Evidence in Healthcare Introduction
11.2.4 IQVIA Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.2.5 IQVIA Recent Development
11.3 ICON
11.3.1 ICON Company Details
11.3.2 ICON Business Overview
11.3.3 ICON Real-World Evidence in Healthcare Introduction
11.3.4 ICON Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.3.5 ICON Recent Development
11.4 PPD
11.4.1 PPD Company Details
11.4.2 PPD Business Overview
11.4.3 PPD Real-World Evidence in Healthcare Introduction
11.4.4 PPD Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.4.5 PPD Recent Development
11.5 Clinigen Group
11.5.1 Clinigen Group Company Details
11.5.2 Clinigen Group Business Overview
11.5.3 Clinigen Group Real-World Evidence in Healthcare Introduction
11.5.4 Clinigen Group Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.5.5 Clinigen Group Recent Development
11.6 Cognizant Technology Solutions Corporation
11.6.1 Cognizant Technology Solutions Corporation Company Details
11.6.2 Cognizant Technology Solutions Corporation Business Overview
11.6.3 Cognizant Technology Solutions Corporation Real-World Evidence in Healthcare Introduction
11.6.4 Cognizant Technology Solutions Corporation Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.6.5 Cognizant Technology Solutions Corporation Recent Development
11.7 Oracle
11.7.1 Oracle Company Details
11.7.2 Oracle Business Overview
11.7.3 Oracle Real-World Evidence in Healthcare Introduction
11.7.4 Oracle Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.7.5 Oracle Recent Development
11.8 Parexel
11.8.1 Parexel Company Details
11.8.2 Parexel Business Overview
11.8.3 Parexel Real-World Evidence in Healthcare Introduction
11.8.4 Parexel Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.8.5 Parexel Recent Development
11.9 PerkinElmer
11.9.1 PerkinElmer Company Details
11.9.2 PerkinElmer Business Overview
11.9.3 PerkinElmer Real-World Evidence in Healthcare Introduction
11.9.4 PerkinElmer Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.9.5 PerkinElmer Recent Development
11.10 SAS Institute
11.10.1 SAS Institute Company Details
11.10.2 SAS Institute Business Overview
11.10.3 SAS Institute Real-World Evidence in Healthcare Introduction
11.10.4 SAS Institute Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.10.5 SAS Institute Recent Development
11.11 UnitedHealth Group
11.11.1 UnitedHealth Group Company Details
11.11.2 UnitedHealth Group Business Overview
11.11.3 UnitedHealth Group Real-World Evidence in Healthcare Introduction
11.11.4 UnitedHealth Group Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.11.5 UnitedHealth Group Recent Development
11.12 Flatiron Health
11.12.1 Flatiron Health Company Details
11.12.2 Flatiron Health Business Overview
11.12.3 Flatiron Health Real-World Evidence in Healthcare Introduction
11.12.4 Flatiron Health Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.12.5 Flatiron Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Real-World Evidence in Healthcare Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Service
Table 3. Key Players of Data Set
Table 4. Global Real-World Evidence in Healthcare Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Real-World Evidence in Healthcare Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Real-World Evidence in Healthcare Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Real-World Evidence in Healthcare Market Share by Region (2020-2025)
Table 8. Global Real-World Evidence in Healthcare Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Real-World Evidence in Healthcare Market Share by Region (2026-2031)
Table 10. Real-World Evidence in Healthcare Market Trends
Table 11. Real-World Evidence in Healthcare Market Drivers
Table 12. Real-World Evidence in Healthcare Market Challenges
Table 13. Real-World Evidence in Healthcare Market Restraints
Table 14. Global Real-World Evidence in Healthcare Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Real-World Evidence in Healthcare Market Share by Players (2020-2025)
Table 16. Global Top Real-World Evidence in Healthcare Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real-World Evidence in Healthcare as of 2024)
Table 17. Ranking of Global Top Real-World Evidence in Healthcare Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Real-World Evidence in Healthcare Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Real-World Evidence in Healthcare, Headquarters and Area Served
Table 20. Global Key Players of Real-World Evidence in Healthcare, Product and Application
Table 21. Global Key Players of Real-World Evidence in Healthcare, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Real-World Evidence in Healthcare Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Real-World Evidence in Healthcare Revenue Market Share by Type (2020-2025)
Table 25. Global Real-World Evidence in Healthcare Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Real-World Evidence in Healthcare Revenue Market Share by Type (2026-2031)
Table 27. Global Real-World Evidence in Healthcare Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Real-World Evidence in Healthcare Revenue Market Share by Application (2020-2025)
Table 29. Global Real-World Evidence in Healthcare Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Real-World Evidence in Healthcare Revenue Market Share by Application (2026-2031)
Table 31. North America Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Real-World Evidence in Healthcare Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Real-World Evidence in Healthcare Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Real-World Evidence in Healthcare Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Real-World Evidence in Healthcare Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Real-World Evidence in Healthcare Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Real-World Evidence in Healthcare Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Real-World Evidence in Healthcare Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2026-2031) & (US$ Million)
Table 46. Anthem Company Details
Table 47. Anthem Business Overview
Table 48. Anthem Real-World Evidence in Healthcare Product
Table 49. Anthem Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 50. Anthem Recent Development
Table 51. IQVIA Company Details
Table 52. IQVIA Business Overview
Table 53. IQVIA Real-World Evidence in Healthcare Product
Table 54. IQVIA Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 55. IQVIA Recent Development
Table 56. ICON Company Details
Table 57. ICON Business Overview
Table 58. ICON Real-World Evidence in Healthcare Product
Table 59. ICON Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 60. ICON Recent Development
Table 61. PPD Company Details
Table 62. PPD Business Overview
Table 63. PPD Real-World Evidence in Healthcare Product
Table 64. PPD Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 65. PPD Recent Development
Table 66. Clinigen Group Company Details
Table 67. Clinigen Group Business Overview
Table 68. Clinigen Group Real-World Evidence in Healthcare Product
Table 69. Clinigen Group Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 70. Clinigen Group Recent Development
Table 71. Cognizant Technology Solutions Corporation Company Details
Table 72. Cognizant Technology Solutions Corporation Business Overview
Table 73. Cognizant Technology Solutions Corporation Real-World Evidence in Healthcare Product
Table 74. Cognizant Technology Solutions Corporation Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 75. Cognizant Technology Solutions Corporation Recent Development
Table 76. Oracle Company Details
Table 77. Oracle Business Overview
Table 78. Oracle Real-World Evidence in Healthcare Product
Table 79. Oracle Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 80. Oracle Recent Development
Table 81. Parexel Company Details
Table 82. Parexel Business Overview
Table 83. Parexel Real-World Evidence in Healthcare Product
Table 84. Parexel Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 85. Parexel Recent Development
Table 86. PerkinElmer Company Details
Table 87. PerkinElmer Business Overview
Table 88. PerkinElmer Real-World Evidence in Healthcare Product
Table 89. PerkinElmer Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 90. PerkinElmer Recent Development
Table 91. SAS Institute Company Details
Table 92. SAS Institute Business Overview
Table 93. SAS Institute Real-World Evidence in Healthcare Product
Table 94. SAS Institute Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 95. SAS Institute Recent Development
Table 96. UnitedHealth Group Company Details
Table 97. UnitedHealth Group Business Overview
Table 98. UnitedHealth Group Real-World Evidence in Healthcare Product
Table 99. UnitedHealth Group Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 100. UnitedHealth Group Recent Development
Table 101. Flatiron Health Company Details
Table 102. Flatiron Health Business Overview
Table 103. Flatiron Health Real-World Evidence in Healthcare Product
Table 104. Flatiron Health Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 105. Flatiron Health Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Real-World Evidence in Healthcare Picture
Figure 2. Global Real-World Evidence in Healthcare Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Real-World Evidence in Healthcare Market Share by Type: 2024 VS 2031
Figure 4. Service Features
Figure 5. Data Set Features
Figure 6. Global Real-World Evidence in Healthcare Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Real-World Evidence in Healthcare Market Share by Application: 2024 VS 2031
Figure 8. Drug Development and Approval Case Studies
Figure 9. Development and Approval of Medical Devices Case Studies
Figure 10. Real-World Evidence in Healthcare Report Years Considered
Figure 11. Global Real-World Evidence in Healthcare Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Real-World Evidence in Healthcare Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Real-World Evidence in Healthcare Market Share by Region: 2024 VS 2031
Figure 14. Global Real-World Evidence in Healthcare Market Share by Players in 2024
Figure 15. Global Top Real-World Evidence in Healthcare Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real-World Evidence in Healthcare as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Real-World Evidence in Healthcare Revenue in 2024
Figure 17. North America Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Real-World Evidence in Healthcare Market Share by Country (2020-2031)
Figure 19. United States Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Real-World Evidence in Healthcare Market Share by Country (2020-2031)
Figure 23. Germany Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Real-World Evidence in Healthcare Market Share by Region (2020-2031)
Figure 31. China Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Real-World Evidence in Healthcare Market Share by Country (2020-2031)
Figure 39. Mexico Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Real-World Evidence in Healthcare Market Share by Country (2020-2031)
Figure 43. Turkey Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Anthem Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 47. IQVIA Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 48. ICON Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 49. PPD Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 50. Clinigen Group Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 51. Cognizant Technology Solutions Corporation Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 52. Oracle Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 53. Parexel Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 54. PerkinElmer Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 55. SAS Institute Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 56. UnitedHealth Group Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 57. Flatiron Health Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Real-World Evidence in Healthcare Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Service
Table 3. Key Players of Data Set
Table 4. Global Real-World Evidence in Healthcare Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Real-World Evidence in Healthcare Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Real-World Evidence in Healthcare Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Real-World Evidence in Healthcare Market Share by Region (2020-2025)
Table 8. Global Real-World Evidence in Healthcare Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Real-World Evidence in Healthcare Market Share by Region (2026-2031)
Table 10. Real-World Evidence in Healthcare Market Trends
Table 11. Real-World Evidence in Healthcare Market Drivers
Table 12. Real-World Evidence in Healthcare Market Challenges
Table 13. Real-World Evidence in Healthcare Market Restraints
Table 14. Global Real-World Evidence in Healthcare Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Real-World Evidence in Healthcare Market Share by Players (2020-2025)
Table 16. Global Top Real-World Evidence in Healthcare Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real-World Evidence in Healthcare as of 2024)
Table 17. Ranking of Global Top Real-World Evidence in Healthcare Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Real-World Evidence in Healthcare Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Real-World Evidence in Healthcare, Headquarters and Area Served
Table 20. Global Key Players of Real-World Evidence in Healthcare, Product and Application
Table 21. Global Key Players of Real-World Evidence in Healthcare, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Real-World Evidence in Healthcare Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Real-World Evidence in Healthcare Revenue Market Share by Type (2020-2025)
Table 25. Global Real-World Evidence in Healthcare Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Real-World Evidence in Healthcare Revenue Market Share by Type (2026-2031)
Table 27. Global Real-World Evidence in Healthcare Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Real-World Evidence in Healthcare Revenue Market Share by Application (2020-2025)
Table 29. Global Real-World Evidence in Healthcare Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Real-World Evidence in Healthcare Revenue Market Share by Application (2026-2031)
Table 31. North America Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Real-World Evidence in Healthcare Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Real-World Evidence in Healthcare Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Real-World Evidence in Healthcare Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Real-World Evidence in Healthcare Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Real-World Evidence in Healthcare Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Real-World Evidence in Healthcare Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Real-World Evidence in Healthcare Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2026-2031) & (US$ Million)
Table 46. Anthem Company Details
Table 47. Anthem Business Overview
Table 48. Anthem Real-World Evidence in Healthcare Product
Table 49. Anthem Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 50. Anthem Recent Development
Table 51. IQVIA Company Details
Table 52. IQVIA Business Overview
Table 53. IQVIA Real-World Evidence in Healthcare Product
Table 54. IQVIA Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 55. IQVIA Recent Development
Table 56. ICON Company Details
Table 57. ICON Business Overview
Table 58. ICON Real-World Evidence in Healthcare Product
Table 59. ICON Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 60. ICON Recent Development
Table 61. PPD Company Details
Table 62. PPD Business Overview
Table 63. PPD Real-World Evidence in Healthcare Product
Table 64. PPD Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 65. PPD Recent Development
Table 66. Clinigen Group Company Details
Table 67. Clinigen Group Business Overview
Table 68. Clinigen Group Real-World Evidence in Healthcare Product
Table 69. Clinigen Group Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 70. Clinigen Group Recent Development
Table 71. Cognizant Technology Solutions Corporation Company Details
Table 72. Cognizant Technology Solutions Corporation Business Overview
Table 73. Cognizant Technology Solutions Corporation Real-World Evidence in Healthcare Product
Table 74. Cognizant Technology Solutions Corporation Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 75. Cognizant Technology Solutions Corporation Recent Development
Table 76. Oracle Company Details
Table 77. Oracle Business Overview
Table 78. Oracle Real-World Evidence in Healthcare Product
Table 79. Oracle Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 80. Oracle Recent Development
Table 81. Parexel Company Details
Table 82. Parexel Business Overview
Table 83. Parexel Real-World Evidence in Healthcare Product
Table 84. Parexel Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 85. Parexel Recent Development
Table 86. PerkinElmer Company Details
Table 87. PerkinElmer Business Overview
Table 88. PerkinElmer Real-World Evidence in Healthcare Product
Table 89. PerkinElmer Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 90. PerkinElmer Recent Development
Table 91. SAS Institute Company Details
Table 92. SAS Institute Business Overview
Table 93. SAS Institute Real-World Evidence in Healthcare Product
Table 94. SAS Institute Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 95. SAS Institute Recent Development
Table 96. UnitedHealth Group Company Details
Table 97. UnitedHealth Group Business Overview
Table 98. UnitedHealth Group Real-World Evidence in Healthcare Product
Table 99. UnitedHealth Group Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 100. UnitedHealth Group Recent Development
Table 101. Flatiron Health Company Details
Table 102. Flatiron Health Business Overview
Table 103. Flatiron Health Real-World Evidence in Healthcare Product
Table 104. Flatiron Health Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
Table 105. Flatiron Health Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Real-World Evidence in Healthcare Picture
Figure 2. Global Real-World Evidence in Healthcare Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Real-World Evidence in Healthcare Market Share by Type: 2024 VS 2031
Figure 4. Service Features
Figure 5. Data Set Features
Figure 6. Global Real-World Evidence in Healthcare Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Real-World Evidence in Healthcare Market Share by Application: 2024 VS 2031
Figure 8. Drug Development and Approval Case Studies
Figure 9. Development and Approval of Medical Devices Case Studies
Figure 10. Real-World Evidence in Healthcare Report Years Considered
Figure 11. Global Real-World Evidence in Healthcare Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Real-World Evidence in Healthcare Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Real-World Evidence in Healthcare Market Share by Region: 2024 VS 2031
Figure 14. Global Real-World Evidence in Healthcare Market Share by Players in 2024
Figure 15. Global Top Real-World Evidence in Healthcare Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real-World Evidence in Healthcare as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Real-World Evidence in Healthcare Revenue in 2024
Figure 17. North America Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Real-World Evidence in Healthcare Market Share by Country (2020-2031)
Figure 19. United States Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Real-World Evidence in Healthcare Market Share by Country (2020-2031)
Figure 23. Germany Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Real-World Evidence in Healthcare Market Share by Region (2020-2031)
Figure 31. China Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Real-World Evidence in Healthcare Market Share by Country (2020-2031)
Figure 39. Mexico Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Real-World Evidence in Healthcare Market Share by Country (2020-2031)
Figure 43. Turkey Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Anthem Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 47. IQVIA Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 48. ICON Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 49. PPD Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 50. Clinigen Group Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 51. Cognizant Technology Solutions Corporation Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 52. Oracle Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 53. Parexel Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 54. PerkinElmer Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 55. SAS Institute Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 56. UnitedHealth Group Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 57. Flatiron Health Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232